Advertisement
Advertisement
BHVN
Biohaven Ltd.
8.39
USDSponsored
-0.35
-3.95%
Mar 24, 15:54 UTC -4
Open
BHVN Earnings Reports
Positive Surprise Ratio
BHVN beat 5 of 14 last estimates.
36%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$599.76K
/-$0.84
Implied change from Q4 25 (Revenue/ EPS)
--
/-30.58%
Implied change from Q1 25 (Revenue/ EPS)
--
/-61.29%
Biohaven Ltd. earnings per share and revenue
On Mar 02, 2026, BHVN reported earnings of -1.21 USD per share (EPS) for Q4 25, beating the estimate of -1.31 USD, resulting in a 8.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.65% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.84 USD, with revenue projected to reach 599.76 thousand USD, implying an decrease of -30.58% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.37
Surprise
-706.10%
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
$0.09
Actual
$0.05
Surprise
-45.53%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
Cellectis S.A. - ADR
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.26
Actual
-$0.26
Surprise
+1.78%
Eledon Pharmaceuticals, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.10
Surprise
+51.78%
Artiva Biotherapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.84
Actual
-Surprise
-
Milestone Pharmaceuticals Inc. Common Shares
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.16
Actual
-$0.16
Surprise
+1.96%
Spruce Biosciences, Inc. Common Stock
Report Date
Apr 13, 2026 For Q4 25
Estimate
-$8.14
Actual
-Surprise
-
Pelthos Therapeutics Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$4.21
Actual
-$2.83
Surprise
+32.82%
Abivax SA - ADR
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.52
Actual
-$1.02
Surprise
+32.82%
FAQ
What were Biohaven Ltd.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Biohaven Ltd. reported EPS of -$1.21, beating estimates by 8%, and revenue of $0.00, 0% as expectations.
How did the market react to Biohaven Ltd.'s Q4 2025 earnings?
The stock price moved down -9.65%, changed from $11.81 before the earnings release to $10.67 the day after.
When is Biohaven Ltd. expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Biohaven Ltd.'s next earnings report?
Based on 11
analysts, Biohaven Ltd. is expected to report EPS of -$0.84 and revenue of $599.76K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement